Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9945
Title: Comorbidities and their impact on chronic obstructive pulmonary disease
Authors: Dursunoğlu, Neşe.
Köktürk, N.
Baha, A.
Bilge, A.K.
Börekçi, Ş.
Çiftçi, F.
Karadağ, M.G.
Keywords: Comorbidity
COPD
C reactive protein
calcium
denosumab
fibrinogen
ghrelin
growth hormone
interleukin 1beta
interleukin 6
megestrol
parathyroid hormone[1-34]
testosterone
tumor necrosis factor
vitamin D
aging
anemia
anxiety
Article
asthma
body mass
chronic obstructive lung disease
clinical trial (topic)
comorbidity
depression
diabetes mellitus
emphysema
family history
gastroesophageal reflux
heart failure
human
hypertension
ischemic heart disease
lung cancer
lung diffusion capacity
lung fibrosis
malnutrition
metabolic syndrome X
musculoskeletal disease
obesity
osteoporosis
respiratory system
sleep disorder
smoking
vitamin D deficiency
Cardiovascular Diseases
disease management
health status
Lung Neoplasms
Musculoskeletal Diseases
Pulmonary Disease, Chronic Obstructive
quality of life
cardiovascular disease
complication
lung tumor
Diabetes Mellitus
Disease Management
Health Status
Humans
Quality of Life
Publisher: Ankara University
Abstract: Chronic obstructive pulmonary disease (COPD) is a complex disease that is associated with devastating outcomes resulting from lung involvement and several comorbidities. Comorbidities could impact on symptomology, quality of life, the complications, the management, economic burden and the mortality of the disease. The importance of comorbidities originates from their impact on the outcome of COPD. The most frequent comorbidities in COPD are cardiovascular, endocrinological, musculoskeletal, phycological disorders and lung cancer. Almost 50% of the COPD patients have 3 or more comorbidities. The recent Global Initiative of Obstructive Lung Disease (GOLD) Guideline suggested proactive search and the treatment of the comorbidities. However, there is no certain evidence demonstrating that active treatment of comorbidities improve the outcomes of COPD. However, it is well known that several comorbidities such as cardiovascular disease and lung cancer have greater impact on mortality caused by COPD. Several studies have shown that Charlson Comorbidity index or more recenty COPD Specific Comorbidity Index (COTE) has been found to be related with mortality of COPD. This concise review intended to summarize the most frequent comorbidities in association with their impact on COPD. © 2016, Ankara University. All rights reserved.
URI: https://hdl.handle.net/11499/9945
https://doi.org/10.5578/tt.2245
ISSN: 0494-1373
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
neşe dursunoğlu.pdf99.07 kBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

7
checked on Nov 23, 2024

WEB OF SCIENCETM
Citations

9
checked on Nov 21, 2024

Page view(s)

48
checked on Aug 24, 2024

Download(s)

20
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.